The study, conducted by a team of doctors at Biel Hospital Centre and published on Monday, analysed photos of shop windows from 68 randomly selected pharmacies in Switzerland. The team found that of the 970 medicines examined, only 418 (or 43.1%) had proven efficacy.
The data on the remaining 556 medicines (or 56.9%) are too thin to draw any reliable conclusions about their effectiveness.
These results can be explained in part by the fact that pharmacies are not allowed to advertise prescription medicines like antibiotics in their windows, notes the study published in the British Medical Journal Open.
“Most of them are homeopathic medicines that have never proved effective in any study. So you can drink gallons of them and you’ll probably have neither primary effects nor side effects,” explained Professor Daniel Genné, who directed the study.
But he told Swiss public broadcaster RTS that this proportion is still problematic. “These are still surprising results, which could also have consequences for patients,” he said.
While the drugs on display are not dangerous to health, Genné points out that they are sold to people with symptoms. “It could just be anxiety, but it could also be a serious illness for which effective treatment needs to be given. So it could delay a diagnosis.”
Genné’s team regrets the presence of so many drugs with no proven efficacy in shop windows. By giving them this visibility, pharmacies are indirectly recommending them to the public, who are increasingly resorting to self-medication. However, some patients are unaware that non-prescription drugs can interact with other medicines.
The researchers are therefore proposing to introduce a label on all non-prescription medicines indicating their level of efficacy, “just as electrical appliances have been classified from A to F according to their level of energy efficiency”. This would enable patients to make informed decisions about the medicines they choose to buy.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Foreign Affairs
How a top Swiss university is screening Chinese students
Media: Swiss medical services done abroad are billed at Swiss rates
This content was published on
In Switzerland, some medical services carried out abroad are still billed at Swiss rates, despite costing less, RTS reports.
This content was published on
Sophie Hediger, a member of the Swiss national snowboard cross team, has died in an avalanche in Arosa. She was 26 years old.
This content was published on
Several Swiss films exceeded the 100,000 admissions mark worldwide in 2024 and received widespread praise at international film festivals.
Swiss Alpine resorts covered in white gold for Christmas
This content was published on
Many areas at low altitudes in Switzerland are enjoying a blanket of snow. In the mountains, intense precipitation has delighted skiers.
SWISS makes emergency landing in Austria after smoke in cockpit
This content was published on
Swiss International Airlines (SWISS) made an emergency landing of an Airbus in Graz, Austria on Monday evening after engine problems.
L’Oréal acquires South Korean subsidiary of Migros’ cosmetics brand
This content was published on
French cosmetics firm L'Oréal is acquiring Gowoonsesang Cosmetics, the South Korean subsidiary of the Migros-owned Mibelle group, for an undisclosed sum.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss government to save CHF250 million with generic drug promotion
This content was published on
Generic drugs will become cheaper than original drugs and patients’ co-payment will increase if they choose the more expensive product.
Swiss cities test controlled cannabis distribution
This content was published on
Swiss drug policy is shifting. Some pharmacies and social clubs in major cities are making cannabis available for recreational purposes.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.